<DOC>
	<DOCNO>NCT02625519</DOCNO>
	<brief_summary>Exploratory , prospective , randomize , comparative , open trial control group treat assess whether effective use urinary FSH ( uFSH ) recombinant FSH ( rFSH ) influence genotype receptor N680S FSH Gene Polymorphism .</brief_summary>
	<brief_title>Efficacy Urinary Vs Recombinant FSH Oocyte Donors Based Receptor N680S FSH Gene Polymorphism ( Genodon Trial )</brief_title>
	<detailed_description>The aim study determine whether number oocyte obtain woman oocyte donor may different use rFSH uFSH base receptor N680S FSHR gene polymorphism . This exploratory , prospective , randomize , comparative , open trial control group treat accord usual therapeutic approach institution ovarian stimulation oocyte donor prospective exploratory study control group . Three group set base follicle-stimulating hormone receptor ( FSHR ) genotype polymorphism N680 : Group SS ( Ser/Ser ) , group SN ( Ser/Asn ) group NN ( Asn/Asn ) . Donor member group randomly assign receive daily 225 IU recombinant urinary FSH control ovarian stimulation protocol antagonist . To avoid unintentional bias , allocation treatment group take place time ovarian stimulation accord begin list random allocation treatment group ( SS , SN NN ) associate code patient prepare available start study . The code assignment treatment patient consecutively order list must record medical history patient . The next scheduled patient assign code next immediate treatment list . The protocol control ovarian stimulation oocyte donor , perform always accord usual protocol Instituto Bernabeu .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Be consider eligible get oocyte donation program Instituto Bernabeu Age 18 30 year Body Mass Index 18 28 Antral follicle count great 9 less 25 ( add ovary ) Patients start ovarian stimulation 225 IU FSH Presence ovaries Ability participate comply study protocol Signing write consent form Not receive treatment ovulation stimulators 3 month prior stimulation Not suitable inclusion oocyte donation program Institute Bernabeu Concurrent participation another study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Controlled ovarian stimulation</keyword>
	<keyword>Follicle-stimulating hormone</keyword>
	<keyword>Receptor N680S follicle-stimulating hormone receptor ( FSHR ) gene polymorphism</keyword>
	<keyword>Oocyte donor</keyword>
</DOC>